{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:40Z","timestamp":1791862240308,"version":"4.3.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T00:00:00Z","timestamp":1285804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00228-010-0902-6","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T06:57:17Z","timestamp":1285743437000},"page":"1177-1187","source":"Crossref","is-referenced-by-count":105,"title":["Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials"],"prefix":"10.1007","volume":"66","author":[{"given":"Luit","family":"Penninga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Steinbr\u00fcchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,30]]},"reference":[{"key":"902_CR1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.healun.2009.08.014","volume":"28","author":"DO Taylor","year":"2009","unstructured":"Taylor DO, Stehlik J, Edwards LB et al (2009) Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report\u20142009. J Heart Lung Transplant 28:1007\u20131022","journal-title":"J Heart Lung Transplant"},{"key":"902_CR2","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0041-1345(00)00862-9","volume":"32","author":"H Valantine","year":"2000","unstructured":"Valantine H (2000) Neoral use in the cardiac transplant recipient. Transplant Proc 32:27S\u201344S","journal-title":"Transplant Proc"},{"key":"902_CR3","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.transproceed.2004.01.018","volume":"36","author":"MH Kapturczak","year":"2004","unstructured":"Kapturczak MH, Meier-Kriesche HU, Kaplan B (2004) Pharmacology of calcineurin antagonists. Transplant Proc 36:25S\u201332S","journal-title":"Transplant Proc"},{"key":"902_CR4","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(89)91014-3","volume":"2","author":"TE Starzl","year":"1989","unstructured":"Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramman R, Jain A (1989) FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000\u20131004","journal-title":"Lancet"},{"key":"902_CR5","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2165\/00003495-200666170-00010","volume":"66","author":"PL McCormack","year":"2006","unstructured":"McCormack PL, Keating GM (2006) Tacrolimus: in heart transplant recipients. Drugs 66:2269\u20132279","journal-title":"Drugs"},{"key":"902_CR6","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2165\/00003495-200666170-00012","volume":"66","author":"NR Banner","year":"2006","unstructured":"Banner NR (2006) Tacrolimus: in heart transplant recipients\u2014a viewpoint by Nicholas R. Banner. Drugs 66:2280\u20132282","journal-title":"Drugs"},{"key":"902_CR7","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S (2009) Cochrane handbook for systematic reviews of interventions version 5.0.2 (updated September 2009). The Cochrane Collaboration. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"902_CR8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006\u20131012","journal-title":"J Clin Epidemiol"},{"key":"902_CR9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","volume":"24","author":"S Stewart","year":"2005","unstructured":"Stewart S, Winters GL, Fishbein MC et al (2005) Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 24:1710\u20131720","journal-title":"J Heart Lung Transplant"},{"issue":"iii","key":"902_CR10","first-page":"ix-51","volume":"7","author":"P Royle","year":"2003","unstructured":"Royle P, Waugh N (2003) Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. Health Technol Assess 7(iii):ix-51","journal-title":"Health Technol Assess"},{"key":"902_CR11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","volume":"273","author":"KF Schulz","year":"1995","unstructured":"Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408\u2013412","journal-title":"JAMA"},{"key":"902_CR12","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"902_CR13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","volume":"326","author":"DG Altman","year":"2003","unstructured":"Altman DG, Bland JM (2003) Interaction revisited: the difference between two estimates. BMJ 326:219","journal-title":"BMJ"},{"key":"902_CR14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C (2008) Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 61:64\u201375","journal-title":"J Clin Epidemiol"},{"key":"902_CR15","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","volume":"6","author":"M Grimm","year":"2006","unstructured":"Grimm M, Rinaldi M, Yonan NA et al (2006) Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2014a large European trial. Am J Transplant 6:1387\u20131397","journal-title":"Am J Transplant"},{"key":"902_CR16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","volume":"25","author":"J Kobashigawa","year":"2006","unstructured":"Kobashigawa J, Patel J, Furukawa H et al (2006) Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 25:434\u2013439","journal-title":"J Heart Lung Transplant"},{"key":"902_CR17","doi-asserted-by":"crossref","unstructured":"Kobashigawa JA, Miller LW, Russell SD (2004) A randomized, prospective, multicenter comparison of tacrolimus, mycopholate mofetil (mmf) and steroids vs cyclosporine microemulsion, mmf and steroids vs tacrolimus, sirolimus and steroids in de novo cardiac transplantation recipients\u20146\u00a0month report. 3rd International Congress on Immunosuppression, San Diego","DOI":"10.1097\/00007890-200407271-00420"},{"key":"902_CR18","unstructured":"Kobashigawa JA, Patel JK, Furukawa H, Marquez A, Oeser BT, Laks H (2004) Five-year results of a randomized single center study of tacrolimus versus microemulsion cyclosporine in heart transplant patients. 3rd International Congress on Immunosuppression, San Diego"},{"key":"902_CR19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","volume":"6","author":"JA Kobashigawa","year":"2006","unstructured":"Kobashigawa JA, Miller LW, Russell SD et al (2006) Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 6:1377\u20131386","journal-title":"Am J Transplant"},{"key":"902_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.TP.0000129814.52456.25","volume":"78","author":"BM Meiser","year":"2004","unstructured":"Meiser BM, Groetzner J, Kaczmarek I et al (2004) Tacrolimus or cyclosporine: which is the better partner for mycophenolate-mofetil in heart transplant recipients? Transplantation 78:591\u2013598","journal-title":"Transplantation"},{"key":"902_CR21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00007890-200004271-00695","volume":"69","author":"BM Meiser","year":"2000","unstructured":"Meiser BM, Scheersoi T, Pfeiffer M et al (2000) Comparison of trough level adjusted MMF application in combination with either cyclosporine or tacrolimus in a randomized study after heart transplantation. Transplantation 69:695","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"902_CR22","first-page":"133","volume":"85","author":"BM Meiser","year":"1996","unstructured":"Meiser BM, Uberfuhr P, Fuchs A et al (1996) Comparison between tacrolimus (FK506) and cyclosporin A (CyA) after heart transplantation: a randomised, controlled clinical study. Zeitschr Kardiol 85 [Suppl 2]:133","journal-title":"Zeitschr Kardiol"},{"key":"902_CR23","first-page":"782","volume":"17","author":"BM Meiser","year":"1998","unstructured":"Meiser BM, Uberfuhr P, Fuchs A et al (1998) Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant 17:782\u2013788","journal-title":"J Heart Lung Transplant"},{"key":"902_CR24","first-page":"1998","volume":"17","author":"B Reichart","year":"1998","unstructured":"Reichart B, Meiser B, Vigano M et al (1998) European multicenter tacrolimus (FK506) heart pilot study: one-year results\u2014European tacrolimus multicenter heart study group. J Heart Lung Transplant 17:1998","journal-title":"J Heart Lung Transplant"},{"key":"902_CR25","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.healun.2004.11.006","volume":"24","author":"SMD Pollock-BarZiv","year":"2008","unstructured":"Pollock-BarZiv SMD, Dipchand AI, McCrindle BW, Nalli N, West LJ (2005) Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up. J Heart Lung Transplant 24:190\u2013194","journal-title":"J Heart Lung Transplant"},{"key":"902_CR26","first-page":"1001","volume":"16","author":"M Rinaldi","year":"1997","unstructured":"Rinaldi M, Pellegrini C, Martinelli L et al (1997) FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. J Heart Lung Transplant 16:1001\u20131010","journal-title":"J Heart Lung Transplant"},{"key":"902_CR27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","volume":"18","author":"DO Taylor","year":"1999","unstructured":"Taylor DO, Barr ML, Radovancevic B et al (1999) A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 18:336\u2013345","journal-title":"J Heart Lung Transplant"},{"key":"902_CR28","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2004.08.059","volume":"36","author":"CH Wang","year":"2004","unstructured":"Wang CH, Ko WJ, Chou N, Wang SS (2004) Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan. Transplant Proc 36:2384\u20132385","journal-title":"Transplant Proc"},{"key":"902_CR29","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/j.transproceed.2004.08.053","volume":"36","author":"CH Wang","year":"2004","unstructured":"Wang CH, Ko WJ, Chou N, Wang SS (2004) Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral. Transplant Proc 36:2386\u20132387","journal-title":"Transplant Proc"},{"key":"902_CR30","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.transproceed.2008.08.072","volume":"40","author":"SS Wang","year":"2008","unstructured":"Wang SS, Chou NK, Chi NH et al (2008) Heart transplantation under cyclosporine or tacrolimus combined with mycophenolate mofetil or everolimus. Transplant Proc 40:2607\u20132608","journal-title":"Transplant Proc"},{"key":"902_CR31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0041-1345(01)01906-6","volume":"33","author":"J Groetzner","year":"2001","unstructured":"Groetzner J, Meiser BM, Schirmer J et al (2001) Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? Transplant Proc 33:1461\u20131464","journal-title":"Transplant Proc"},{"key":"902_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1053-2498(00)00398-3","volume":"20","author":"J Groetzner","year":"2001","unstructured":"Groetzner J, Meiser B, Schirmer J et al (2001) Tacrolimus\/mycophenolate mofetil vs cyclosporine\/mycophenolate mofetil: comparison of mycophenolate mofetil acid trough levels and coronary vasomotor function. J Heart Lung Transplant 20:191","journal-title":"J Heart Lung Transplant"},{"key":"902_CR33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1053-2498(01)00615-5","volume":"21","author":"J Groetzner","year":"2002","unstructured":"Groetzner J, Meiser B, Schirmer J et al (2002) Tacrolimus\/mycophenolate mofetil vs cyclosporine\/mycophenolate mofetil: impact on infections following cardiac transplantation. J Heart Lung Transplant 21:120","journal-title":"J Heart Lung Transplant"},{"key":"902_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1053-2498(00)00399-5","volume":"20","author":"J Schirmer","year":"2001","unstructured":"Schirmer J, Meiser B, Kadner A et al (2001) Tacrolimus versus cyclosporine after HTX: comparison of long-term effects. J Heart Lung Transplant 20:191","journal-title":"J Heart Lung Transplant"},{"key":"902_CR35","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S1053-2498(02)00732-5","volume":"22","author":"M Grimm","year":"2003","unstructured":"Grimm M, Rinaldi M, Yonan NA (2003) Efficacy and safety of tacrolimus (TAC) vs. cyclosporine microemulsion (CME) in de novo cardiac transplant recipients: 6-month results. J Heart Lung Transplant 22:S92","journal-title":"J Heart Lung Transplant"},{"key":"902_CR36","first-page":"72","volume":"16","author":"DO Taylor","year":"1997","unstructured":"Taylor DO, Barr ML, Radovancevic B et al (1997) A comparison of tacrolimus- and cyclosporine-based immunosuppression in cardiac transplantation. J Heart Lung Transplant 16:72","journal-title":"J Heart Lung Transplant"},{"key":"902_CR37","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2005.10.073","volume":"47","author":"P Petrakopoulou","year":"2006","unstructured":"Petrakopoulou P, Anthopoulou L, Muscholl M et al (2006) Coronary endothelial vasomotor function and vascular remodeling in heart transplant recipients randomized for tacrolimus or cyclosporine immunosuppression. J Am Coll Cardiol 47:1622\u20131629","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"902_CR38","doi-asserted-by":"crossref","first-page":"S609","DOI":"10.1111\/j.1432-2277.2000.tb02117.x","volume":"13","author":"N von Steinb\u00fcchel","year":"2000","unstructured":"von Steinb\u00fcchel N, Limm H, Leopold C, Carr D (2000) Assessment of health-related quality-of-life in patients after heart transplantation under therapy with tacrolimus or cyclosporine. Transpl Int 13 [Suppl 1]:S609\u2013S614","journal-title":"Transpl Int"},{"key":"902_CR39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1053-2498(00)00567-2","volume":"20","author":"B Reichart","year":"2001","unstructured":"Reichart B, Meiser B, Vigano M et al (2001) European multicenter tacrolimus heart pilot study: three year follow-up. J Heart Lung Transplant 20:249\u2013250","journal-title":"J Heart Lung Transplant"},{"key":"902_CR40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","volume":"163","author":"LL Gluud","year":"2006","unstructured":"Gluud LL (2006) Bias in clinical intervention research. Am J Epidemiol 163:493\u2013501","journal-title":"Am J Epidemiol"},{"key":"902_CR41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00007890-200101150-00012","volume":"71","author":"HJ Eisen","year":"2001","unstructured":"Eisen HJ, Hobbs RE, Davis SF et al (2001) Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine\u2014results at 24\u00a0months after transplantation. Transplantation 71:70\u201378","journal-title":"Transplantation"},{"key":"902_CR42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/01.TP.0000140965.83682.D6","volume":"79","author":"BK Podesser","year":"2005","unstructured":"Podesser BK, Rinaldi M, Yona NA et al (2005) Comparison of low and high initial tacrolimus dosing in primary heart transplant recipients: a prospective European multicenter study. Transplantation 79:65\u201371","journal-title":"Transplantation"},{"key":"902_CR43","doi-asserted-by":"crossref","first-page":"442S","DOI":"10.1016\/j.transproceed.2004.01.004","volume":"36","author":"M Cantarovich","year":"2004","unstructured":"Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J (2004) History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion. Transplant Proc 36:442S\u2013447S","journal-title":"Transplant Proc"},{"key":"902_CR44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.healun.2009.05.022","volume":"28","author":"M Iversen","year":"2009","unstructured":"Iversen M, Nilsson F, Sipponen J et al (2009) Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study. J Heart Lung Transplant 28:919\u2013926","journal-title":"J Heart Lung Transplant"},{"key":"902_CR45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.healun.2008.10.004","volume":"28","author":"Y Fan","year":"2009","unstructured":"Fan Y, Xiao YB, Weng YG, Hetzer R (2009) Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: a meta-analysis. J Heart Lung Transplant 28:58\u201366","journal-title":"J Heart Lung Transplant"},{"key":"902_CR46","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0041-1345(00)02611-7","volume":"33","author":"MR Mehra","year":"2001","unstructured":"Mehra MR, Uber PA, Park MH, Prasad AK, Scott RL (2001) A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. Transplant Proc 33:1606\u20131607","journal-title":"Transplant Proc"},{"key":"902_CR47","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","volume":"6","author":"VC McAlister","year":"2006","unstructured":"McAlister VC, Haddad E, Renouf E, Malthaner RA, Kjaer MS, Gluud LL (2006) Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis. Am J Transplant 6:1578\u20131585","journal-title":"Am J Transplant"},{"key":"902_CR48","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/bmj.38569.471007.AE","volume":"331","author":"AC Webster","year":"2005","unstructured":"Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC (2005) Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ 331:810\u2013821","journal-title":"BMJ"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0902-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-010-0902-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-010-0902-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:10:41Z","timestamp":1559693441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-010-0902-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,30]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["902"],"URL":"https:\/\/doi.org\/10.1007\/s00228-010-0902-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725450168.793506264","asserted-by":"object"}]},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,30]]}}}